Meeder Asset Management Inc Atri Cure, Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $114 - $157	-3 Reduced 42.86%	4 $0
Q1 2022 May 10, 2022	BUY	$57.43 - $71.39 $402 - $499	7 New	7 $0
Q4 2021 Feb 11, 2022	SELL	$63.4 - $87.14 $507 - $697	-8 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$34.56 - $57.55 $34 - $57	1 Added 14.29%	8 $0
Q3 2020 Nov 02, 2020	SELL	$38.36 - $46.91 $13,694 - $16,746	-357 Reduced 98.08%	7 $0
Q2 2020 Aug 11, 2020	SELL	$31.78 - $51.19 $22,246 - $35,833	-700 Reduced 65.79%	364 $15,000
Q1 2020 May 15, 2020	BUY	$24.49 - $43.84 $17,730 - $31,740	724 Added 212.94%	1,064 $37,000
Q4 2019 Feb 13, 2020	BUY	$24.06 - $32.51 $8,180 - $11,053	340 New	340 $11,000

213

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.97B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.